Kodirov S A, Brunner M, Busconi L, Koren G
Bioelectricity Laboratory, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
FEBS Lett. 2003 Aug 28;550(1-3):74-8. doi: 10.1016/s0014-5793(03)00822-6.
Overexpression of a dominant-negative truncated Kv1.1 (Kv1DN) polypeptide in the mouse heart resulted in marked attenuation of a 4-aminopyridine (4-AP)-sensitive current, I(K,slow1). We used recombinant adeno-associated virus (rAAV) as a vector for direct delivery of Kv1.5 into the mouse myocardium in order to normalize the action potential duration (APD) 6 months after injection. The injection of rAAV-Kv1.5 reconstituted the 4-AP-sensitive outward potassium currents, shortened the APD, and eliminated spontaneous early afterdepolarizations. Immunoblots detected the FL-Kv1.5 polypeptides only in rAAV-Kv1.5-infected hearts. These data demonstrate long-term expression of 4-AP-sensitive potassium currents in ventricular myocytes by gene transfer using rAAV vector encodes Kv1.5.
在小鼠心脏中过表达显性负性截短型Kv1.1(Kv1DN)多肽导致4-氨基吡啶(4-AP)敏感电流I(K,slow1)显著减弱。我们使用重组腺相关病毒(rAAV)作为载体将Kv1.5直接递送至小鼠心肌,以便在注射6个月后使动作电位时程(APD)恢复正常。注射rAAV-Kv1.5可重建4-AP敏感的外向钾电流,缩短APD,并消除自发性早期后去极化。免疫印迹仅在rAAV-Kv1.5感染的心脏中检测到全长Kv1.5多肽。这些数据表明,通过使用编码Kv1.5的rAAV载体进行基因转移,可在心室肌细胞中长期表达4-AP敏感的钾电流。